Cleared Traditional

K142978 - Audit MicroControls Linearity LQ Specia...

K142978 is the FDA 510(k) clearance for Audit MicroControls Linearity LQ Specia... by Aalto Scientific, Ltd.. It is a Class 1 Chemistry device (product code JJY) cleared through the Traditional 510(k) pathway after a 36-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2014
Decision
36d
Days
Class 1
Risk

K142978 is an FDA 510(k) clearance for the Audit MicroControls Linearity LQ Special Diabetes. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Aalto Scientific, Ltd. (Carlsbad, US). The FDA issued a Cleared decision on November 20, 2014 after a review of 36 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Aalto Scientific, Ltd. devices

Submission Details

510(k) Number K142978 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 15, 2014
Decision Date November 20, 2014
Days to Decision 36 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 88d · This submission: 36d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 320
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K142978.
RANDOX CSF CONTROLS LEVELS 2 AND 3
K132156 · Randox Laboratories, Ltd. · Oct 2013
V8 SP NORMAL CONTROL, ABNORMAL CONTROL
K131479 · Helena Laboratories · Oct 2013
LIQUICHEK PEDIATRIC CONTROL, LEVEL 1
K130963 · Bio-Rad Laboratories, Inc. · May 2013
RANDOX IMMUNOASSAY SPECIALITY CONTROL (II), LEVEL 1, LEVEL 2 AND LEVEL 3
K121603 · Randox Laboratories, Ltd. · Nov 2012
RANDOX MATERNAL CONTROL, LEVELS 1, 2 AND 3
K113720 · Randox Laboratories, Ltd. · Sep 2012
RANDOX LIQUID IMMUNOASSAY PREMIUM CONTROLS, LEVEL 1, LEVEL2, LEVEL 3 AND TRI LEVEL
K112337 · Randox Laboratories, Ltd. · Dec 2011